What Is Crystalline Silica? Forms, Health Risks and Where It Is Used

Published: Source: Silica Raw Materials News Section: Silica Raw Materials

📌 Key Takeaways

  • Topic: Crystalline Silica Powder: Grades, Uses and Safe Handling Requirements
  • Keywords: silica in makeup powder
  • Published: 2026-11-20 02:28:45
  • Field: Silica (SiO₂) raw materials · Inorganic non-metallic materials · Chemicals
Cordeiro, R. A., Mendonça, P. V., Coelho, J. & Faneca, H. Engineering silica-polymer hybrid nanosystems for dual drug and gene delivery. Biomater. Adv. 135, 212742 (2022). Post CAS PubMed Google Scholar

Quartz Sand Price: 2026 Price Ranges by Purity and Mesh Size

Aerosil 200: Specifications, Applications and Equivalent Fumed Silica Grades
Liong, M. et al. Multifunctional inorganic nanoparticles for imaging, targeting, and drug delivery. ACS Nano 2, 889-896 (2008). Article CAS PubMed Central PubMed Google Scholar
Solvay Zeosil: Highly Dispersible Silica Grades for Tires and Rubber
Li, R., Mei, X., Li, X., Zhang, C. & Ruan, L. A bolt-like-blocking nanovalve on mesoporous silica nanoparticles for controlled release. Micropor. Mesopor. Mater. 317, 111007 (2021). Article CAS Google Scholar
Silicon Carbide vs Silica: Differences in Hardness, Structure and Uses
Raza, A. et al. Microfluidic assembly of pomegranate-like hierarchical microspheres for efflux regulation in oral drug delivery. Acta Biomater. 126, 277-290 (2021). Article CAS PubMed Google Scholar
Quartz Sand for Photovoltaic: High Purity Requirements for Solar Crucibles
Perton, F. et al. Fluorescent and magnetic stellate mesoporous silica for bimodal imaging and magnetic hyperthermia. Appl. Mater. Today 16, 301-314 (2019). Article Google Scholar

HDK N20: Specifications, Applications and Equivalent Grades

What is silica (SiO₂)?

silica industry outlook

What is the difference between fumed silica and precipitated silica?

silica gel manufacturer

What drives silica raw material prices?

silica price trend Targeted delivery tactics are generally divided into two categories: passive targeting and active targeting. Passive targeting relies on the pathological qualities of the disease microenvironment and the nature of the drug delivery system itself, which allows the drug to effectively accumulate at the lesion site of disease. The most well-known passive targeting is the EPR effect of tumor, which refers to the phenomenon that some particles with particular size (20-200 nm) penetrate more without difficulty into tumor tissue and remain there for a long time when compared to normal tissue. 316, 317 Therefore, controlling the size of MSNs to a fitting range will facilitate their enrichment in the tumor sites. However, it has also been highlighted that the passive targeting strategy relying on the EPR effect can attain only 0.7% of the injected NPs enrichment in solid tumors, 318 which will not be handy for the clinical translation of nanotechnology. In contrast, active targeting relies on the active recognition between the molecules on the NPs surface and the specific molecules or proteins in the illness microenvironment, which is also referred to as ligand-receptor specific binding. 319 The active targeting shows a higher drug delivery efficiency compared to passive targeting. 320 Targeted ligands, such as proteins, antibodies, peptides, nucleic acids and chemical tiny molecules, can be modified on the surface of MSNs, and the modified MSNs are capable of selectively aggregating at the lesion site based on the powerful affinity between the targeted ligands and the particular receptors overexpressed in the sickness microenvironment. 321, 322, 323, 324 For instance, compared to mature vascular endothelial cells, tumor neovascular endothelial cells are highly expressed in an array of proteins, such as integrins, transmembrane glycoproteins and aminopeptidase N. Molecules that recognize these highly expressed proteins can be used for neovascular-based targeted drug delivery. A standard example is that arginylglycylaspartic acid (RGD)-modified MSNs can selectively bind integrin α ν β 3 receptor and hence be applied to target tumor neovascularization. 325

Cite this article: Silica Raw Materials News. "Silica Industry Outlook 2026: Challenges, Opportunities and Growth Areas ." Published 2026-11-20 02:28:45. /news/article.html
Disclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.